Millbrae, CA, United States of America

Tamiko Katsumoto

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tamiko Katsumoto. Retrieved from https://idiyas.com/inventor/tamiko-katsumoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 25.0

 

Average Co-Inventor Count = 6.3

ph-index = 1


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind of Tamiko Katsumoto: Pioneering IRAK4 Modulators in Millbrae.

Introduction: Tamiko Katsumoto, a talented inventor based in Millbrae, CA, has made significant contributions to the field of pharmaceuticals with his groundbreaking patents.

Latest Patents: Among his impressive portfolio of 3 patents, Tamiko Katsumoto's latest inventions involve Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators. These compounds, described in great detail in various formulas, demonstrate their efficacy as inhibitors for Interleukin-1 Receptor Associated Kinase (IRAK4).

Career Highlights: Tamiko Katsumoto is a key player at Genentech, Inc., where his innovative spirit thrives. His dedication to research and development has led to the creation of impactful pharmaceutical solutions that have the potential to revolutionize the industry.

Collaborations: In his professional journey, Tamiko Katsumoto has had the pleasure of collaborating with esteemed coworkers such as Marian C Bryan and James Richard Kiefer, Jr. Their combined efforts have undoubtedly propelled the success of their projects at Genentech, Inc.

Conclusion: Tamiko Katsumoto's inventive prowess shines brightly in the realm of pharmaceutical innovations. His dedication to advancing IRAK4 modulators showcases his commitment to pioneering solutions that have the potential to enhance healthcare outcomes globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…